GlassScriptPhysician profile
Thomas G Hunter
NPI 1871702530
$6,585.74
in general payments reported to CMS, 2019-2025
13 companies · $661 in 2025
The $661 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,443 · 2020: $1,555 · 2021: $105 · 2022: $328 · 2023: $290 · 2024: $204 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $4,377.76 | 2019-2022 | |
| Glaukos Corporation | $532.66 | 2019-2025 | Iaccess Precision Blade, Istent Infinite Trabecular Micro-Bypass System Model Is3, Iprime Viscodelivery System |
| Nova Eye, INC. | $279.75 | 2025 | |
| Alcon Vision LLC | $254.99 | 2019-2025 | Argos |
| Bausch & Lomb Americas INC. | $232.85 | 2024-2025 | Xiidra, Miebo |
| Quidel Corporation | $213.52 | 2019 | |
| Amgen INC. | $205.53 | 2019-2024 | Tepezza |
| Microsurgical Technology, INC. | $132.79 | 2022 | |
| Sight Sciences, INC. | $122.20 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $100.00 | 2019 | |
| New World Medical,INC. | $72.00 | 2019 | |
| Allergan, INC. | $49.71 | 2019 | |
| Carl Zeiss Meditec Cataract Technology INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.